ECMP 2026

DOSIsoft participates as sponsor in the 6th European Conference of Medical Physics (ECMP)

DOSIsoft booth #15 | September 23-26, 2026 | Valencia, Spain


ThinkQA 3.0 – Unified PSQA

Designed to streamline the Patient QA Experience

Combining speed, accuracy & simplicity into a unified platform, ThinkQA 3.0 is a next-generation Patient-Specific Quality Assurance (PSQA) solution, designed to support online ART workflow, for both CT-Linacs and MR-Linacs. 

  • Automated PSQA: GPU-powered 3D Collapsed Cone Convolution (CCC) algorithm delivering QA results in just 1-2 minutes
  • Integrated workflow: seamless integration into Elekta ONE without adding time to the routine QA process
  • Centralized QA Management: all pre- & post- treatment PSQA tasks managed within a single and connected platform
  • Simplified QA user experience: Enhanced usability and modern web-based access to improve efficiency and ease of use

Check out also how ThinkQA 3.0 is seamlessly integrated into Elekta One Online adaptive workflow to deliver end-to-end QA features

  • Secondary dose calc: Independent full 3D dose calculation, automatically handling adapt-to-position and adapt-to-shape plans
  • Logfile delivery analysis: Automated pre-treatment and in vivo treatment verifications, based on machine delivery logs, and computed into 3D dose distributions
  • Pretreatment check: EPID-based phantom-less QA providing instant gamma-based comparison results
  • In vivo dosimetry check: EPID-based transit dosimetry QA for dose deviation detection during patient treatment

PLANET® v3.2 – Patient Specific Theranostics SIRT & MRT

Enhancing dosimetry automation

End-to-end, versatile, and vendor-neutral, PLANET is an “All-in-One” platform for 3D voxel-based personalized dosimetry.

  • Multi-radionuclide: Advanced voxel-based dose computation for 90Y-SIRT as well as 177Lu and 131I-based MRT therapies, with the flexibility to incorporate emerging beta and gamma emitters.
  • Multi-workflow: Multi-time point and the newly introduced single-time point dosimetry workflows—streamlining clinical processes, reducing workload, and improving patient comfort while maintaining high dosimetric accuracy.
  • Multi-therapies:  177Lu-PSMA , 177Lu-PRRT for neuroendocrine tumors, 90Y or 166Ho radioembolization¹³¹I-mIBG for neuroblastoma, radioiodine treatment for hyperthyroidism and thyroid cancer, and more.

Experience the new features:

  • AutoSegment: automatic AI-powered segmentation of organs
  • AutoDetect: one-click automatic detection of lesions 
  • AutoFit: automatic best-fit selection for pharmacokinetic modeling

Come and Attend our 15-min industry session Combining EBRT and MRT/SIRT Dosimetry: The ComboDose Framework” presented by Angélique Rivot, Application Specialist at DOSIsoft.

Click on the link provided for more information: ECMP 2026